Blog

Convalescent plasma as a potential therapy for COVID-19 (The Lancet) The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, China, has become a major concern…

Can Phage Therapy be the potential answer? Bacteriophages also called phages are bacteria-attacking microorganisms that devour selected bacteria without causing any harm to the host. Phages are all around us…

Antibiotics are used as a prophylactic agents during this viral pandemic. In future, Can phage therapy be used as for empirical treatment? In study: Phages used for therapeutic or prophylactic…

1. Mutations in the receptor-binding domain of SARS-CoV-2: The receptor binding domain (RBD) in the spike protein is the most variable part of the coronavirus genome. Six RBD amino acids…

Coronaviruses are not particularly hard to please when it comes to potential hosts -- they've been detected in many mammal and bird species, including dogs and cats, as well as…

In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, even…

The proximal origin of SARS-CoV-2- Nature Medicine The genomic features described here may explain in part the infectiousness and transmissibility of SARS-CoV-2 in humans.Although the evidence shows that SARSCoV-2 is…

Right now the world is at war. But this is no ordinary war. It’s a fight with an organism so small we can only detect it through use of a…

--Three Clinical Sites to Enroll Patients with Recurrent and Complicated Urinary Tract Infections-- GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response…

The Cystic Fibrosis Foundation has awarded up to $5 million to Armata Pharmaceuticals to advance its potential treatment AP-PA02 — a phage therapy against multidrug-resistant Pseudomonas aeruginosa infections in cystic…